The estimated Net Worth of Jing L. Marantz is at least $622 mil dollars as of 14 June 2024. Dr Marantz owns over 3,131 units of Krystal Biotech Inc stock worth over $622,411 and over the last 4 years he sold KRYS stock worth over $0.
Sign up
Dr D KRYS stock SEC Form 4 insiders trading
Dr has made over 1 trades of the Krystal Biotech Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently he exercised 3,131 units of KRYS stock worth $622,411 on 14 June 2024.
The largest trade he's ever made was exercising 3,131 units of Krystal Biotech Inc stock on 14 June 2024 worth over $622,411. On average, Dr trades about 348 units every 0 days since 2021. As of 14 June 2024 he still owns at least 3,131 units of Krystal Biotech Inc stock.
You can see the complete history of Dr Marantz stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Jing L. Marantz M.B.A., M.D., Ph.D. biography
Dr. Jing L. Marantz M.B.A., M.D., Ph.D. is the Chief Bus. Officer at Krystal Biotech Inc.
How old is Dr D?
Dr D is 56, he's been the Chief Bus. Officer of Krystal Biotech Inc since . There are no older and 10 younger executives at Krystal Biotech Inc.
Insiders trading at Krystal Biotech Inc
Over the last 7 years, insiders at Krystal Biotech Inc have traded over $166,816,526 worth of Krystal Biotech Inc stock and bought 536,800 units worth $5,949,380 . The most active insiders traders include Daniel Janney, Dino A Rossi y Krish S Krishnan. On average, Krystal Biotech Inc executives and independent directors trade stock every 40 days with the average trade being worth of $8,043,043. The most recent stock trade was executed by Suma Krishnan on 11 June 2024, trading 50,000 units of KRYS stock currently worth $8,788,000.
What does Krystal Biotech Inc do?
krystal biotech, inc. is using gene therapy to develop effective and novel treatments for skin diseases. our goal is to make a meaningful difference in the lives of underserved patient populations with debilitating skin diseases. we work to accomplish that through scientific innovation, operational excellence and believe that “nature operates in the shortest way possible”. (aristotle)
What does Krystal Biotech Inc's logo look like?
Complete history of Dr Marantz stock trades at Krystal Biotech Inc, Arcturus Therapeutics Inc y Scholar Rock Corp
Krystal Biotech Inc executives and stock owners
Krystal Biotech Inc executives and other stock owners filed with the SEC include:
-
Krish S. Krishnan M.B.A., M.S.,
Founder, Chairman, Pres & CEO -
Krish S. Krishnan,
Chairman, Pres & CEO -
Dr. Andreas C. Orth,
Exec. VP & Chief Commercial Officer -
Suma M. Krishnan,
Founder, COO & Director -
Krish Krishnan,
Chairman of the Board, President, Chief Executive Officer -
Suma Krishnan,
Founder, Chief Operating Officer, Director -
Pooja Agarwal,
Senior Vice President, Product Development -
Kathryn A. Romano,
Chief Accounting Officer -
R. Douglas Norby,
Lead Independent Director -
Dino Rossi,
Independent Director -
Daniel Janney,
Independent Director -
Julian Gangolli.,
Independent Director -
Ashley Robinson,
IR Contact Officer -
Kirti Ganorkar,
Independent Director -
J. Christopher Naftzger,
Chief Legal Officer, Corporate Secretary -
Jennifer Chien,
Chief Commercial Officer -
Kathryn Romano,
Chief Accounting Officer -
David Glynn,
Gen. Counsel, Commercial & Compliance -
Meg Dodge,
VP of Investor Relations & Corp. Communications -
Dr. Jing L. Marantz M.B.A., M.D., Ph.D.,
Chief Bus. Officer -
Pooja Agarwal,
Sr. VP of Product Devel. -
Whitney Glad Ijem,
Sr. VP of Strategy & Bus. Devel. -
Josh Suskin,
Director of HR & Operations -
Katherine Tuminello,
HR & Office Mang. -
John Karakkal,
VP of North American Sales and Marketing -
Gloria Lin,
Accounting Mang. -
Catherine Mazzacco,
Director -
Krish S Krishnan,
President and CEO -
Antony A Riley,
Chief Financial Officer -
Jennifer Kayden Lee,
Chief Commercial Officer -
Christopher Mason,
Director -
Jing L. Marantz,
Chief Business Officer -
Everett Rand Sutherland,
Director